Raphael Pharmaceutical Inc. financial data

Symbol
RAPH on OTC
Industry
Medicinal Chemicals & Botanical Products
Location
Suite 105 5348 Vegas Dr., Las Vegas, Nevada
State of incorporation
Nevada
Fiscal year end
December 31
Former names
Easy Energy Inc (to 5/14/2021)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 102 % -17.2%
Return On Equity -8.99K % -329%
Return On Assets -517 % +69.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.7M shares +15.7%
Common Stock, Shares, Outstanding 18.7M shares +16.6%
Entity Public Float 10M USD
Common Stock, Value, Issued 187K USD +16.9%
Weighted Average Number of Shares Outstanding, Basic 18.6M shares +16.6%
Weighted Average Number of Shares Outstanding, Diluted 18.6M shares +16.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 834K USD -30.8%
General and Administrative Expense 727K USD -66.9%
Operating Income (Loss) -1.56M USD +54.1%
Nonoperating Income (Expense) -9K USD +75.7%
Net Income (Loss) Attributable to Parent -1.57M USD +54.3%
Earnings Per Share, Basic 0.08 USD/shares -66.7%
Earnings Per Share, Diluted 0.08 USD/shares -66.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 287K USD +655%
Other Assets, Current 63K USD -43.2%
Assets, Current 350K USD +135%
Assets 353K USD +135%
Accrued Liabilities, Current 152K USD -7.88%
Liabilities, Current 456K USD +187%
Retained Earnings (Accumulated Deficit) -7.86M USD -25%
Stockholders' Equity Attributable to Parent -103K USD -1044%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -9K USD -109%
Liabilities and Equity 353K USD +135%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -172K USD +56.9%
Net Cash Provided by (Used in) Financing Activities 230K USD +54.4%
Net Cash Provided by (Used in) Investing Activities -1K USD
Common Stock, Shares Authorized 21M shares 0%
Common Stock, Shares, Issued 18.7M shares +16.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 57K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 287K USD +655%
Deferred Tax Assets, Valuation Allowance 1.28M USD +75.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 1.28M USD +75.4%
Depreciation 1K USD
Payments to Acquire Property, Plant, and Equipment 1K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.36M USD +107%
Deferred Tax Assets, Operating Loss Carryforwards 5.77M USD +80.2%
Additional Paid in Capital 7.18M USD +52.5%